Skip directly to content

NeisVac-C (meningococcal group C polysaccharide conjugate vaccine adsorbed)

What is NeisVac-C® (meningococcal group C polysaccharide conjugate vaccine adsorbed) and what is it used for?

NeisVac-C is a conjugate vaccine that helps to provide protection against invasive disease caused by Neisseria meningitidis serogroup C. Invasive disease occurs when the bacterium spreads through the body causing serious infections such as septicaemia (blood infection) and meningitis (infection of the membranes around the brain and spinal cord).  

This vaccine will only protect against disease caused by the meningococci group C bacteria. It will not protect against infections caused by other groups of meningococci or other organisms that cause meningitis and blood poisoning. As with other vaccines, NeisVac-C may not completely prevent meningococcal group C infections in all people who are vaccinated.  

When should the vaccine be administered?

NeisVac-C is indicated for active immunisation in children from 2 months of age, adolescents and adults. The recommended dosing schedule for NeisVac-C should be determined on the basis of official recommendations.

The medicine can only be obtained with a prescription.

Reference information
PP-NVC-GBR-0020 / Oct 2017

Pfizer is unable to provide advice on personal medical matters. Please consult your doctor or other relevant health professionals for specific, health-related advice and support.

If you get any side effects when taking this or any other medicine, talk to your doctor or other relevant health professional e.g. pharmacist, nurse.. This includes any possible side effects not listed in the packaging leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.